V VERICEL CORP
| Market Cap | $1.74B |
| P/E Ratio | 106.69 |
| Forward P/E | 44.80 |
| Dividend Yield | — |
| Beta | 1.21 |
| 52W Range | $29.34 - $45.70 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Biotechnology |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Mairs & Power Growth Fund Mairs & Power Inc | 0.01% | $931.00K | 25,865 | — |
Insider Trading
| Insider Name of the company insider who made the trade 15 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Hagen Heidi | Sale | 15,000 | $32.41 | $486.15K | 23 Mar 2026 | 23 Mar 2026 |
| Flynn Sean C.Chief Legal Officer | Sale | 15,000 | $35.36 | $530.40K | 02 Mar 2026 | 04 Mar 2026 |
| Flynn Sean C.Chief Legal Officer | Sale | 6,421 | $34.75 | $223.13K | 02 Mar 2026 | 04 Mar 2026 |
| Halpin MichaelChief Operating Officer | Sale | 10,305 | $35.30 | $363.77K | 02 Mar 2026 | 04 Mar 2026 |
| MCLAUGHLIN KEVIN F | Sale | 7,000 | $34.66 | $242.62K | 11 Feb 2026 | 13 Feb 2026 |
| Halpin MichaelChief Operating Officer | Sale | 10,000 | $40.48 | $404.80K | 07 Jan 2026 | 09 Jan 2026 |
| Wotton Paul K | Sale | 2,500 | $37.83 | $94.58K | 03 Dec 2025 | 04 Dec 2025 |
| Paul K WottonDirector | Sale | 2,500 | $37.83 | $94.58K | 03 Dec 2025 | 04 Dec 2025 |
| Hopper Jonathan MarkChief Medical Officer | Sale | 1,652 | $39.14 | $64.66K | 02 Dec 2025 | 04 Dec 2025 |
| Wotton Paul K | Sale | 2,500 | $37.97 | $94.92K | 02 Dec 2025 | 04 Dec 2025 |
| Paul K WottonDirector | Sale | 2,500 | $37.97 | $94.92K | 02 Dec 2025 | 04 Dec 2025 |
| Jonathan Mark HopperChief Medical Officer | Sale | 1,652 | $39.14 | $64.66K | 02 Dec 2025 | 04 Dec 2025 |
| Halpin MichaelChief Operating Officer | Sale | 2,642 | $40.41 | $106.76K | 11 Nov 2025 | 13 Nov 2025 |
| MCLAUGHLIN KEVIN F | Sale | 7,000 | $38.59 | $270.13K | 10 Nov 2025 | 12 Nov 2025 |
| Halpin MichaelChief Operating Officer | Sale | 7,358 | $40.47 | $297.78K | 06 Nov 2025 | 10 Nov 2025 |
Frequently Asked Questions
What is VCEL stock price today?
VERICEL CORP (VCEL) is currently trading at $34.14. The stock has a 52-week range of $29.34 to $45.70 and a market capitalization of $1.74B.
Is VCEL a good stock to buy in 2026?
VERICEL CORP has a P/E ratio of 106.7 (forward P/E: 44.8), a dividend yield of none, and 1-year performance of -21.5%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling VCEL stock?
There have been 15 insider transactions for VCEL in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has VCEL stock performed over the past year?
VERICEL CORP (VCEL) has returned -21.5% over the past 12 months. The stock traded between $29.34 and $45.70 during this period, and is currently at $34.14.
Which hedge funds own VCEL (VERICEL CORP)?
1 tracked hedge funds currently hold VCEL in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is VCEL's market cap and valuation?
VERICEL CORP (VCEL) has a market capitalization of $1.74B. The trailing P/E ratio is 106.7 and forward P/E is 44.8. The stock is classified in the Healthcare sector.
What is VCEL's revenue and profitability?
VERICEL CORP reported revenue of $276.26M with net income of $16.52M and a profit margin of 0.06%. The stock has a beta of 1.21.
What sector is VCEL in and who are its biggest institutional holders?
VERICEL CORP (VCEL) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.